why-you-should-take-part-in-a-clinical-trial

What Monitoring Looks Like Without a Site Visit

Monitoring does not disappear in decentralised trials. It evolves. Less about binders, more about patterns, systems and conversations that still matter.
(4 min)

Decentralised trials do not eliminate monitoring, they just change where and how it happens. In many cases, the absence of a physical site visit shifts the focus from “checking the binder” to understanding systems, signals, and patterns.

This is not a downgrade. It is a reorientation.

From Spot Checks to Continuous Oversight

Traditional monitoring was cyclical: visits every 4–6 weeks, followed by query resolution. In a digital-first setup, the rhythm changes:

  • eCRF data is reviewed daily or weekly
  • Query turnaround is tracked in real time
  • System alerts flag missing or conflicting entries

The result? Less catch-up, more flow.

Skills and Tools That Matter Now

  • Comfort with systems: Navigating platform logic, audit views, and permissions
  • Pattern recognition: Spotting not just errors, but signals — slow form entry, repeat deviations, incomplete uploads
  • Clear written communication: Queries are now documents, not hallway chats. The tone and clarity matter more.
  • Document literacy: Being able to cross-reference protocols, CRFs, and logs without flipping through a folder

Remote monitors need to be both technically fluent and operationally sharp.

What Gets Missed Without a Visit

There are trade-offs:

  • You might not notice whether paper source notes match expectations
  • Body language during PI meetings disappears
  • Study coordinators may be juggling more than they let on

That means remote monitoring works best when paired with proactive communication - structured calls, shared dashboards, and transparent ticketing systems.

Rethinking the Aim of Monitoring

Replacing site visits isn’t the point. The goal is to preserve quality and oversight using whatever mix of tools and interactions is appropriate for the study.

Some trials still benefit from site visits. Others thrive with digital monitoring. Many use both. What matters is that monitoring remains timely, relevant, and human.

Use the contact form here or email us at hello@trialflare.com

Related Posts

Post-Market Data Collection Without Overburdening Participants
The trial may end, but the data journey continues. Post-market studies demand new ways of collecting meaningful, low-burden data.
(4 min)
Phase 3 Trials and the Limits of Flexibility
In Phase 3 trials, flexibility is not about lowering standards. It is about designing systems that adapt without breaking.
(4 min)